Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This postmarketing observational study will evaluate the safety of ADASUVE® in treating patients with agitation associated with schizophrenia or bipolar I disorder.
Epistemonikos ID: f11b8040a5704a051114e4deee61099e86657fe0
First added on: May 21, 2024